Literature DB >> 29463618

Evaluation of the Role of stat3 in Antibody and TH17-Mediated Responses to Pneumococcal Immunization and Infection by Use of a Mouse Model of Autosomal Dominant Hyper-IgE Syndrome.

Kristin Moffitt1, Elaine Cheung2, John Manis3, Richard Malley2.   

Abstract

Loss-of-function mutations in the signal transducer and activator of transcription 3 gene (stat3) result in autosomal dominant hyper-IgE syndrome (AD-HIES), a condition in which patients have recurrent debilitating infections, including frequent pneumococcal and staphylococcal pneumonias. stat3 mutations cause defective adaptive TH17 cellular responses, an immune mechanism believed to be critical for clearance of pneumococcal colonization and diminished antibody responses. Here we wished to evaluate the role of stat3 in the clearance of pneumococcal carriage and immunity using mice with a stat3 mutation recapitulating AD-HIES. We show here that naive AD-HIES mice have prolonged nasal carriage of pneumococcus compared to WT mice. Mutant and wild-type mice were then immunized with a pneumococcal whole-cell vaccine (WCV) that provides TH17-mediated protection against pneumococcal colonization and antibody-mediated protection against pneumonia and sepsis. WCV-immunized AD-HIES mice made significantly less pneumococcus-specific interleukin-17A (IL-17A) and antibody than WT mice. The WCV-elicited protection against colonization was abrogated in AD-HIES mice, but immunization with WCV still protected AD-HIES mice against aspiration pneumonia/sepsis. Taken together, our results suggest that impaired clearance of nasopharyngeal carriage due to poor adaptive IL-17A responses may contribute to the increased rates of pneumococcal respiratory infection in AD-HIES patients.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  IL-17A; Job's syndrome; Streptococcus pneumoniae; autosomal dominant hyper-IgE syndrome; pneumococcal vaccine

Mesh:

Substances:

Year:  2018        PMID: 29463618      PMCID: PMC5913858          DOI: 10.1128/IAI.00024-18

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

1.  Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci.

Authors:  R Malley; M Lipsitch; A Stack; R Saladino; G Fleisher; S Pelton; C Thompson; D Briles; P Anderson
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency.

Authors:  Capucine Picard; Horst von Bernuth; Pegah Ghandil; Maya Chrabieh; Ofer Levy; Peter D Arkwright; Douglas McDonald; Raif S Geha; Hidetoshi Takada; Jens C Krause; C Buddy Creech; Cheng-Lung Ku; Stephan Ehl; László Maródi; Saleh Al-Muhsen; Sami Al-Hajjar; Abdulaziz Al-Ghonaium; Noorbibi K Day-Good; Steven M Holland; John I Gallin; Helen Chapel; David P Speert; Carlos Rodriguez-Gallego; Elena Colino; Ben-Zion Garty; Chaim Roifman; Toshiro Hara; Hideto Yoshikawa; Shigeaki Nonoyama; Joseph Domachowske; Andrew C Issekutz; Mimi Tang; Joanne Smart; Simona Eva Zitnik; Cyrille Hoarau; Dinakantha S Kumararatne; Adrian J Thrasher; E Graham Davies; Claire Bethune; Nicolas Sirvent; Dominique de Ricaud; Yildiz Camcioglu; Júlia Vasconcelos; Margarida Guedes; Artur Bonito Vitor; Carlos Rodrigo; Francisco Almazán; Maria Méndez; Juan Ignacio Aróstegui; Laia Alsina; Claudia Fortuny; Janine Reichenbach; James W Verbsky; Xavier Bossuyt; Rainer Doffinger; Laurent Abel; Anne Puel; Jean-Laurent Casanova
Journal:  Medicine (Baltimore)       Date:  2010-11       Impact factor: 1.889

3.  Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination.

Authors:  M S Dworkin; J W Ward; D L Hanson; J L Jones; J E Kaplan
Journal:  Clin Infect Dis       Date:  2001-02-28       Impact factor: 9.079

4.  GMP-grade pneumococcal whole-cell vaccine injected subcutaneously protects mice from nasopharyngeal colonization and fatal aspiration-sepsis.

Authors:  Ying-Jie Lu; Luciana Leite; Viviane Maimoni Gonçalves; Waldely de Oliveira Dias; Celia Liberman; Fernando Fratelli; Mark Alderson; Andrea Tate; Jean-François Maisonneuve; George Robertson; Rita Graca; Sabina Sayeed; Claudette M Thompson; Porter Anderson; Richard Malley
Journal:  Vaccine       Date:  2010-09-19       Impact factor: 3.641

5.  Impaired antibody responses in the hyperimmunoglobulin E syndrome.

Authors:  D Y Leung; D M Ambrosino; R D Arbeit; J L Newton; R S Geha
Journal:  J Allergy Clin Immunol       Date:  1988-06       Impact factor: 10.793

6.  The impact of HIV on Streptococcus pneumoniae bacteraemia in a South African population.

Authors:  N Jones; R Huebner; M Khoosal; H Crewe-Brown; K Klugman
Journal:  AIDS       Date:  1998-11-12       Impact factor: 4.177

Review 7.  The fundamental link between pneumococcal carriage and disease.

Authors:  Birgit Simell; Kari Auranen; Helena Käyhty; David Goldblatt; Ron Dagan; Katherine L O'Brien
Journal:  Expert Rev Vaccines       Date:  2012-07       Impact factor: 5.217

8.  Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life.

Authors:  B M Gray; G M Converse; H C Dillon
Journal:  J Infect Dis       Date:  1980-12       Impact factor: 5.226

9.  Nasopharyngeal pneumococcal carriage rates among HIV-infected adults following widespread pediatric use of conjugate pneumococcal vaccine-13.

Authors:  Theresa D Feola; Cynthia A Bonville; Donald A Cibula; Sherly Jose; Geetha Nattanmai; Joseph B Domachowske; Manika Suryadevara
Journal:  Hum Vaccin Immunother       Date:  2016-05-24       Impact factor: 3.452

10.  Interleukin-17A mediates acquired immunity to pneumococcal colonization.

Authors:  Ying-Jie Lu; Jane Gross; Debby Bogaert; Adam Finn; Linda Bagrade; Qibo Zhang; Jay K Kolls; Amit Srivastava; Anna Lundgren; Sophie Forte; Claudette M Thompson; Kathleen F Harney; Porter W Anderson; Marc Lipsitch; Richard Malley
Journal:  PLoS Pathog       Date:  2008-09-19       Impact factor: 6.823

View more
  1 in total

1.  Generation of protective pneumococcal-specific nasal resident memory CD4+ T cells via parenteral immunization.

Authors:  Richard Malley; Bruce H Horwitz; Joanne M O'Hara; Naresh S Redhu; Elaine Cheung; Nahid G Robertson; Izabel Patik; Shorouk El Sayed; Claudette M Thompson; Muriel Herd; Katherine B Lucas; Evan Conaway; Cynthia C Morton; Donna L Farber
Journal:  Mucosal Immunol       Date:  2019-10-28       Impact factor: 7.313

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.